STAT+
Unpacking ‘Food Noise’: Ro’s Innovative Scale Transforming Obesity Care Through Telehealth
Telehealth companies are making a significant impact on how we understand and treat obesity, especially with the surge of new ... Read more
Impact of Ongoing Government Shutdown: Medicare Payments to Doctors Temporarily Halted
The Centers for Medicare and Medicaid Services (CMS) is hitting pause on Medicare payments to doctors. This decision comes as ... Read more
Explosive Growth in Digital Health M&A: How AI and Private Equity Are Shaping the Future
Earlier this year, Tom Stanis faced a tough choice for his startup, Story Health. The company helps providers manage heart ... Read more
Impending Government Shutdown: Over 32,000 HHS Employees Face Furloughs, Affecting CDC and CMS Communication
More than 32,000 employees from the Department of Health and Human Services are facing furloughs. The Centers for Disease Control ... Read more
Exciting New Arrival: Former FDA Digital Leader Joins Mayo Clinic to Boost Innovation!
Sonja Fulmer recently made a significant career switch from the FDA to the Mayo Clinic, marking her transition into health ... Read more
House Bill Slashes HHS Budget: What It Means for RFK Jr.’s Reorganization and NIH Funding
House appropriators recently moved forward with a funding bill that has both good and bad news for researchers. The Republican-led ... Read more
Why Major Health Care Companies are Urging Congress to Renew ACA Insurance Subsidies: What You Need to Know
The healthcare industry is gearing up for a major lobbying effort to keep the enhanced subsidies that help many people ... Read more
Novo Nordisk’s Wegovy: Breakthrough Obesity Drug Now Approved for Treating MASH
Novo Nordisk’s drug, Wegovy, recently received approval from U.S. regulators to treat a common liver disease called metabolic dysfunction-associated steatohepatitis ... Read more
How Staff Cuts are Jeopardizing Federal Research Essential for Improving Healthcare
A small federal agency dedicated to improving the healthcare system is struggling after losing a significant portion of its staff. ... Read more
Vinay Prasad Makes a Comeback at the FDA: What His Return Means for Public Health
Vinay Prasad is back at the Food and Drug Administration (FDA) to lead the Center for Biologics Evaluation and Research. ... Read more
